A five year follow-up study of tardive dyskinesia
Chouinard, G.; Annable, L.; Mercier, P.; Ross-Chouinard, A.
Psychopharmacology Bulletin 22(1): 259-263
1986
ISSN/ISBN: 0048-5764 PMID: 2873614 Document Number: 280976
Document emailed within 1 workday
Related Documents
Kane, J.M.; Woerner, M.; Weinhold, P.; Wegner, J.; Kinon, B.; Borenstein, M. 1984: Incidence of tardive dyskinesia: five-year data from a prospective study Psychopharmacology Bulletin 20(3): 387-389Bajulaiye, R.; Addonizio 1992: Clozapine in the treatment of psychosis in an 82-year-old woman with tardive dyskinesia Journal of Clinical Psychopharmacology 12(5): 364-365
Huh, L.; Lee, B.Ju. 2015: Efficacy of aripiprazole in antidepressants-induced tardive dystonia and tardive dyskinesia: a case report Psychiatria Danubina 27(2): 195-197
Camp, E.W. 1977: Tardive dyskinesia oral facial dyskinesia with moban Diseases of the Nervous System 38(9): 759
Myslobodsky, M.S.; Holden, T.; Sandler, R. 1986: Parkinsonian symptoms in tardive dyskinesia. A prevalence study South African Medical Journal 69(7): 424-426
Asnis, G.M. 1977: Tardive dyskinesia: is it or is it not? a review of the problems in diagnosis and a case study Diseases of the Nervous System 38(10): 856-859
Kane, J.M.; Woerner, M.; Weinhold, P.; Wegner, J.; Kinon, B. 1982: A prospective study of tardive dyskinesia development: preliminary results Journal of Clinical Psychopharmacology 2(5): 345-349
Pandurangi, A.K.; Devi, V.; Channabasavanna, S.M. 1980: Caudate atrophy in irreversible tardive dyskinesia (a pneumoencephalographic study) Journal of Clinical Psychiatry 41(7): 229-231
Sajjad, S.H. 1998: Vitamin E in the treatment of tardive dyskinesia: a preliminary study over 7 months at different doses International Clinical Psychopharmacology 13(4): 147-155
Lohr, J.B.; Lohr, M.A.; Wasli, E.; Hilliard, B.; Larson, L.; Vardiman, E.; Wade, L.; Jeste, D.V. 1987: Self-perception of tardive dyskinesia and neuroleptic-induced parkinsonism: a study of clinical correlates Psychopharmacology Bulletin 23(1): 211-214
Gualtieri, C.T.; Sprague, R.L. 1984: Preventing tardive dyskinesia and preventing tardive dyskinesia litigation Psychopharmacology Bulletin 20(3): 346-348
Karniol, I.G.; Portela, W. 1982: Oxprenolol in schizophrenic patients with tardive dyskinesia: a double-blind placebo-controlled, crossover study Brazilian Journal of Medical and Biological Research 15(6): 389-394
Mehta, D.; Eaton, J.; Burch, M.; Mehta, S. 1985: Observations in tardive dyskinesia Journal of Clinical Psychiatry 46(2): 73
Wolf, M.E.; DeWolfe, A.S.; Ryan, J.J.; Lips, O.; Mosnaim, A.D. 1985: Vulnerability to tardive dyskinesia Journal of Clinical Psychiatry 46(9): 367-368
Gunne, L.M.; Häggström, J.E.; Johansson, P.; Levin, E.D.; Terenius, L. 1988: Neurobiochemical changes in tardive dyskinesia L'Encephale 14(Special Issue): 167-173
Gardos, G.; Sokol, M.; Cole, J.O.; Sniffin, C. 1976: Eye color and tardive dyskinesia Psychopharmacology Bulletin 12(2): 7 8-7 9
Chowdhury, K.L.; Jalali, R.K.; Abrol, A.; Saproo, R.K.; Shah, B.A.; Tramboo, R. 1991: Polypharmacy and tardive dyskinesia Journal of the Association of Physicians of India 39(6): 501-503
Gunne, L.M.; Häggström, J.E. 1985: Experimental tardive dyskinesia Journal of Clinical Psychiatry 46(4 Pt 2): 48-50
Granacher, R.P. 1978: The tardive dyskinesia syndrome Journal of the Kentucky Medical Association 76(1): 13-17
Calne, D.B.; Claveria, L.E.; Teychenne, P.F.; Haskayne, L.; Lodge-Patch, I.C. 1974: Pimozide in tardive dyskinesia Transactions of the American Neurological Association 99: 166-170